Missing/wrong data?
Log in to edit
Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease
scientific article published in February 2003
Author/s
author: Hubert Scharnagl, Wolfgang Koenig, Nikolaus Marx
Work details
Publication date
February 1, 2003
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.